These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8544587)

  • 21. Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
    Melichart M; Kyrle PA; Eichinger S; Rintelen C; Mannhalter C; Pabinger I
    Wien Klin Wochenschr; 1996; 108(19):607-10. PubMed ID: 8921576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
    Zöller B; Svensson PJ; He X; Dahlbäck B
    J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human genetics. Bad blood by mutation.
    Majerus PW
    Nature; 1994 May; 369(6475):14-5. PubMed ID: 8164730
    [No Abstract]   [Full Text] [Related]  

  • 24. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to activated protein C: a common inherited cause of venous thrombosis.
    Gillespie DL; Carrington LR; Griffin JH; Alving BM
    Ann Vasc Surg; 1996 Mar; 10(2):174-7. PubMed ID: 8733870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor V Leiden--an unselfish gene?
    Hajjar KA
    N Engl J Med; 1994 Dec; 331(23):1585-7. PubMed ID: 7969330
    [No Abstract]   [Full Text] [Related]  

  • 27. Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V.
    Greengard JS; Xu X; Gandrille S; Griffin JH
    Thromb Res; 1995 Dec; 80(5):441-3. PubMed ID: 8588206
    [No Abstract]   [Full Text] [Related]  

  • 28. Further evidence that activated protein C resistance affects protein C coagulant activity assays.
    Jennings I; Kitchen S; Cooper PC; Rimmer JE; Woods TA; Preston FE
    Thromb Haemost; 2000 Jan; 83(1):171-2. PubMed ID: 10669173
    [No Abstract]   [Full Text] [Related]  

  • 29. Mutation in blood coagulation factor V associated with resistance to activated protein C.
    Bertina RM; Koeleman BP; Koster T; Rosendaal FR; Dirven RJ; de Ronde H; van der Velden PA; Reitsma PH
    Nature; 1994 May; 369(6475):64-7. PubMed ID: 8164741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor V Leiden mutation and venous thrombosis.
    Davies KA; Ireland H; Athanassiou P; Loizou S; Lane D; Walport MJ
    Lancet; 1995 Jan; 345(8942):132-3. PubMed ID: 7815875
    [No Abstract]   [Full Text] [Related]  

  • 31. Venous thrombosis after extracorporeal shock-wave lithotripsy in a patient with heterozygous APC-resistance.
    Brodmann M; Ramschak H; Schreiber F; Stark G; Pabst E; Pilger E
    Thromb Haemost; 1998 Nov; 80(5):861. PubMed ID: 9843186
    [No Abstract]   [Full Text] [Related]  

  • 32. [Breakthrough in thrombosis research--can the use of contraceptive pills be safer than it used to be?].
    Lähteenmäki P
    Duodecim; 1995; 111(22):2097-8. PubMed ID: 9841168
    [No Abstract]   [Full Text] [Related]  

  • 33. Are we ready for factor V Leiden screening?
    Dahlbäck B
    Lancet; 1996 May; 347(9012):1346-7. PubMed ID: 8637335
    [No Abstract]   [Full Text] [Related]  

  • 34. [A newly discovered blood coagulation disorder. Resistance to activated protein C as a cause of thrombosis].
    Dahlbäck B; Svensson PJ
    Lakartidningen; 1994 Jan; 91(1-2):50-3. PubMed ID: 8289554
    [No Abstract]   [Full Text] [Related]  

  • 35. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).
    Simioni P; Prandoni P; Lensing AW; Scudeller A; Sardella C; Prins MH; Villalta S; Dazzi F; Girolami A
    N Engl J Med; 1997 Feb; 336(6):399-403. PubMed ID: 9010145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent ulcerations on both legs since early childhood due to a factor V gene mutation.
    Hackenjos K; Bek M; Schöpf E; Vanscheidt W
    Dermatology; 1997; 194(3):297-8. PubMed ID: 9187855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.
    Bertina RM; Reitsma PH; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1995 Jul; 74(1):449-53. PubMed ID: 8578504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two novel (R(-11)C; T394D) and two repeat missense mutations in the protein C gene associated with venous thrombosis in six kindreds.
    Ireland HA; Boisclair MD; Taylor J; Thompson E; Thein SL; Girolami A; De Caterina M; Scopacasa F; De Stefano V; Leone G; Finazzi G; Cohen H; Lane DA
    Hum Mutat; 1996; 7(2):176-9. PubMed ID: 8829639
    [No Abstract]   [Full Text] [Related]  

  • 39. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Activated protein C resistance and mutation of coagulation factor V].
    Samama MM
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):669-70. PubMed ID: 8760650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.